Novel Agents in the Management of Mycobacterium Tuberculosis Disease

E-ISSN： 1875-533x|14|18|2000-2008

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.18, 2007-08, pp. : 2000-2008

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Hydrazide Agents to Inhibit Growth and Proliferation of Mycobacterium Tuberculosis

Medicinal Chemistry, Vol. 8, Iss. 2, 2012-03 ,pp. : 273-280

Bentham Science Publishers

Access to resources Recommend Favorite

Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis Agents

Current Clinical Pharmacology, Vol. 10, Iss. 1, 2015-04 ,pp. : 66-72

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis

Current Medicinal Chemistry, Vol. 22, Iss. 14, 2015-05 ,pp. : 1745-1756

Bentham Science Publishers

Access to resources Recommend Favorite

DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-08 ,pp. : 4455-4473

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Agents in the Management of Lung Cancer

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4291-4325

Bentham Science Publishers

Access to resources Recommend Favorite